NCT00218153View on ClinicalTrials.gov

Naltrexone Augmentation of Nicotine Patch Therapy - 1

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2000

Study Completion Date

April 30, 2004

Conditions
Tobacco Use Disorder
Interventions
DRUG

Naltrexone

Trial Locations (2)

06519

Substance Abuse Treatment Unit, New Haven

VA Connecticut Health Care System, New Haven

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00218153 - Naltrexone Augmentation of Nicotine Patch Therapy - 1 | Biotech Hunter | Biotech Hunter